Deciphera Pharmaceuticals Inc (DCPH)
25.46
+0.02
(+0.06%)
USD |
NASDAQ |
May 17, 16:00
25.46
0.00 (0.00%)
After-Hours: 20:00
Deciphera Pharmaceuticals Cash from Financing (Quarterly): 0.522M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.522M |
| December 31, 2023 | 0.89M |
| September 30, 2023 | 15.59M |
| June 30, 2023 | 0.838M |
| March 31, 2023 | 134.69M |
| December 31, 2022 | 0.478M |
| September 30, 2022 | 0.209M |
| June 30, 2022 | 164.22M |
| March 31, 2022 | 0.083M |
| December 31, 2021 | 1.978M |
| September 30, 2021 | 1.706M |
| June 30, 2021 | 1.682M |
| March 31, 2021 | 9.524M |
| December 31, 2020 | 27.79M |
| September 30, 2020 | 3.228M |
| Date | Value |
|---|---|
| June 30, 2020 | 4.389M |
| March 31, 2020 | 191.39M |
| December 31, 2019 | 0.761M |
| September 30, 2019 | 434.48M |
| June 30, 2019 | 0.019M |
| March 31, 2019 | 1.118M |
| December 31, 2018 | 0.06M |
| September 30, 2018 | -0.504M |
| June 30, 2018 | 186.47M |
| March 31, 2018 | -0.036M |
| December 31, 2017 | 127.49M |
| September 30, 2017 | -2.775M |
| June 30, 2017 | 51.74M |
| March 31, 2017 | -0.051M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
0.019M
Minimum
Jun 2019
434.48M
Maximum
Sep 2019
49.72M
Average
1.842M
Median
Cash from Financing (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 14.64B |
| Dynavax Technologies Corp | -4.203M |
| Gilead Sciences Inc | -1.361B |
| Esperion Therapeutics Inc | 90.61M |
| SINTX Technologies Inc | 5.328M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -54.58M |
| Cash from Investing (Quarterly) | 62.63M |
| Free Cash Flow | -152.39M |
| Free Cash Flow Per Share (Quarterly) | -0.6263 |
| Free Cash Flow to Equity (Quarterly) | -54.73M |
| Free Cash Flow Yield | -6.94% |